[1] 管海燕, 杨文斌. 药物性肝损伤患者临床特点及预后分析. 实用肝脏病杂志, 2021, 29(5):713-716. [2] 李银玲, 翁丽媚, 吴思思, 等. 药物性肝损伤时肾生物化学指标的改变及其临床意义. 中华肝脏病杂志, 2019, 27(2):143-145. [3] Kim A, Koo JH, Lee JM, et al. NRF2-mediated SIRT3 induction protects hepatocytes from ER stress-induced liver injury. FASEB J, 2022, 36(3):e22170. [4] Bardallo GR, Panisello-Roselló A, Sanchez-Nuno S, et al. Nrf2 and oxidative stress in liver ischemia/reperfusion injury. FEBS J, 2022, 289(18):5463-5479. [5] 中华医学会, 中华医学会杂志社, 中华医学会消化病学分会,等. 药物性肝损伤基层诊疗指南(2019年). 中华全科医师杂志, 2020, 19(10):868-875. [6] 中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南.中华肝脏病杂志, 2015, 23(11):810-820. [7] Lao TT. Drug-induced liver injury in pregnancy. BestPract Res Clin Obstet Gynaecol, 2020, 68(10):32-43. [8] Wang CY, Deng Y, Li P, et al. Prediction of biochemical nonresolution in patients with chronic drug-induced liver injury: a large multicenter study. Hepatology, 2022, 75(6):1373-1385. [9] Bakshi S, Kaur M, Saini N, et al. Altered expressions of circulating microRNAs 122 and 192 during antitubercular drug induced liver injury indicating their role as potential biomarkers. Hum Exp Toxicol, 2021, 40(9):1474-1484. [10] Gibson A, Hammond S,Jaruthamsophon K, et al. Tolvaptan- and tolvaptan-metabolite-responsive T cells in patients with drug-induced liver injury. Chem Res Toxicol, 2020, 33(11):2745-2748. [11] Zhang F,Xu H, Yuan Y, et al. Lyophyllum decastes fruiting body polysaccharide alleviates acute liver injury by activating the Nrf2 signaling pathway. Food Funct, 2022, 13(4):2057-2067. [12] 张晓倩, 杨慧, 孟蝶, 等. 原发性胆汁性胆管炎患者血清核因子相关因子2、血红素加氧酶1的含量与熊去氧胆酸短期应答的相关性. 中华临床医师杂志:电子版, 2020, 14(5):364-369. [13] Kakisaka K, Suzuki Y, Jinnouchi Y, et al. Unfavorable prognosis of patients with acute liver injury due to drug‐induced liver injury and acute exacerbation of hepatitis B virus infection. Hepatol Res, 2019, 49(11):1286-1293. [14] 罗珂, 丁莉, 刘美. 慢性乙型肝炎患者血清miR-21和miR-148b水平变化及其预测肝组织炎症分级和纤维化分期价值探讨. 实用肝脏病杂志, 2022, 25(3):335-338. [15] Ghanim BY, Ahmad MI, Abdallah QM, et al. Modulation of NRF2/ARE pathway- and cell death-related genes during drug-induced liver injury. Hum Exp Toxicol, 2021, 40(12):2223-2236. [16] Chen Y,Duan J. Diagnostic value of peripheral blood miR-148a-3p in patients with liver injury after hepatectomy under general anesthesia with propofol. Clin Lab, 2020, 66(3):1-10. [17] Guo S, Yu M, Fang Q, et al. Heme oxygenase-1 induction mitigates burn-associated early acute kidney injury via the TLR4 signaling pathway. Burns, 2022, 48(1):156-167. [18] Meng Z, Wang L, Liao Y, et al. The protective effect of heme oxygenase-1 on liver injury caused by DON-induced oxidative stress and cytotoxicity. Toxins (Basel), 2021, 13(10):732-738. [19] Mousavi K, Niknahad H, Li H, et al. The activation of nuclear factor-E2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) signaling blunts cholestasis-induced liver and kidney injury. Toxicol Res (Camb), 2021, 10(4):911-927. [20] Sasson A, Kristoferson E, Batista R, et al. The pivotal role of heme oxygenase-1 in reversing the pathophysiology and systemic complications of NAFLD. Arch Biochem Biophys, 2021, 697(1):108679. [21] Du J, Ren W, Zhang Q, et al. Heme oxygenase-1 suppresses wnt signaling pathway in nonalcoholic steatohepatitis-related liver fibrosis. Biomed Res Int, 2020, 21(12):1-15. |